Skip to main content
# Title Research Department Research Year
46 Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer’s-like pathology and symptoms through multiple targeting actions in aged T2D rats Department of Pharmacology 2023
47 The prognostic value of post thyroidectomy Tc-99m pertechnetate thyroid scan in patients with differentiated thyroid cancer Department of Clinical Oncology and Nuclear Medicine 2023
48 Plasma brain natriuretic peptide, D-Dimer, and serum troponin-I as predictors for in-hospital death in patients with COVID-19 Department of Clinical Pathology 2023
49 Validity of Serum Zinc Copper Ratio as a Potential Novel Biomarker in Childhood Epilepsy Department of Biochemistry 2023
50 Trichloroacetic Acid With Microneedling Versus Trichloroacetic Acid Alone for Treating Melasma Department of Dermatology, Venereology and Andrology 2023
51 Cytotoxic n‑Hexane Fraction of the Egyptian Pteris vittata Functions as Anti‑breast Cancer Through Coordinated Actions on Apoptotic and Autophagic Pathways Department of Biochemistry 2023
52 Graves’ disease in children: an update Department of Pediatrics 2023
53 Interstitial Cystitis/Bladder Pain Syndrome: Role of Bladder Inflammation in Bladder Function Department of Urology 2023
54 Topiramate affords neuroprotection in diabetic neuropathy model via downregulating spinal GFAP/inflammatory burden and improving neurofilament production Department of Pharmacology 2023